SNES - SenesTech, Inc.
Previous close
3.105
-0.025 -0.805%
Share volume: 7
Last Updated: Thu 26 Dec 2024 06:19:52 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$3.13
-0.03
-0.80%
Fundamental analysis
40%
Profitability
25%
Dept financing
7%
Liquidity
75%
Performance
55%
Performance
5 Days
12.68%
1 Month
32.34%
3 Months
22.44%
6 Months
393.65%
1 Year
288.26%
2 Year
-90.91%
Key data
Stock price
$3.10
DAY RANGE
$3.13 - $3.13
52 WEEK RANGE
$0.51 - $5.80
52 WEEK CHANGE
$79.77
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Joel Fruendt
Region: US
Website: senestech.com
Employees: 30
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: senestech.com
Employees: 30
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
SenesTech, Inc. develops technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and headquartered in Phoenix, Arizona.
Recent news